Keywords: amgen, Epogen, aranesp, class action, conneticut

Amgen in firing line as Supreme Court OKs anemia drug lawsuits

Article | 28 February 2013

Print This

Amgen will have to defend itself against lawsuits from shareholders claiming it misled investors

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in